Corvus Pharmaceuticals, Inc. (CRVS)

Corvus Pharmaceuticals Statistics

Total Valuation

CRVS has a market cap or net worth of $1.08 billion. The enterprise value is $817.77 million.

Market Cap	1.08B
Enterprise Value	817.77M

Important Dates

The last earnings date was Thursday, May 7, 2026, after market close.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

CRVS has 84.09 million shares outstanding. The number of shares has increased by 24.98% in one year.

Current Share Class	84.09M
Shares Outstanding	84.09M
Shares Change (YoY)	+24.98%
Shares Change (QoQ)	+8.48%
Owned by Insiders (%)	3.51%
Owned by Institutions (%)	75.02%
Float	72.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.26
P/TBV Ratio	4.38
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 19.81, with a Debt / Equity ratio of 0.00.

Current Ratio	19.81
Quick Ratio	19.65
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -30.46% and return on invested capital (ROIC) is -20.52%.

Return on Equity (ROE)	-30.46%
Return on Assets (ROA)	-19.16%
Return on Invested Capital (ROIC)	-20.52%
Return on Capital Employed (ROCE)	-19.88%
Weighted Average Cost of Capital (WACC)	9.39%
Revenue Per Employee	n/a
Profits Per Employee	-$1.19M
Employee Count	37
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +240.49% in the last 52 weeks. The beta is 0.94, so CRVS's price volatility has been similar to the market average.

Beta (5Y)	0.94
52-Week Price Change	+240.49%
50-Day Moving Average	14.82
200-Day Moving Average	11.19
Relative Strength Index (RSI)	38.72
Average Volume (20 Days)	1,653,880

Short Selling Information

The latest short interest is 18.39 million, so 21.86% of the outstanding shares have been sold short.

Short Interest	18.39M
Short Previous Month	16.93M
Short % of Shares Out	21.86%
Short % of Float	25.26%
Short Ratio (days to cover)	14.90

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-47.93M
Pretax Income	-44.17M
Net Income	-44.17M
EBITDA	-47.81M
EBIT	-47.93M
Earnings Per Share (EPS)	-$0.55

Balance Sheet

The company has $236.71 million in cash and $834,000 in debt, with a net cash position of $235.88 million or $2.81 per share.

Cash & Cash Equivalents	236.71M
Total Debt	834,000
Net Cash	235.88M
Net Cash Per Share	$2.81
Equity (Book Value)	240.68M
Book Value Per Share	2.86
Working Capital	227.84M

Cash Flow

In the last 12 months, operating cash flow was -$34.91 million and capital expenditures -$229,000, giving a free cash flow of -$35.14 million.

Operating Cash Flow	-34.91M
Capital Expenditures	-229,000
Depreciation & Amortization	112,000
Net Borrowing	n/a
Free Cash Flow	-35.14M
FCF Per Share	-$0.42

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRVS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.98%
Shareholder Yield	-24.98%
Earnings Yield	-4.19%
FCF Yield	-3.33%

Analyst Forecast

The average price target for CRVS is $33.33, which is 158.37% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$33.33
Price Target Difference	158.37%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2